Align Technology (ALGN) Current Deferred Revenue (2009 - 2026)
Align Technology's (ALGN) quarterly Current Deferred Revenue came in at $1.2 billion in Q1 2026, down 6.38% year-on-year from $1.3 billion in Q1 2025, and down 8.32% on a QoQ basis from $1.3 billion in Q4 2025.
Align Technology (ALGN) Current Deferred Revenue (2009 - 2026) Analysis & Trends
Align Technology (ALGN) has 18 years of Current Deferred Revenue data on file, last reported at $1.2 billion in Q1 2026.
- On a quarterly basis, Current Deferred Revenue fell 6.38% year-over-year to $1.2 billion in Q1 2026; TTM through Mar 2026 was $1.2 billion, a 6.38% decrease from a year earlier, with the FY2025 full-year figure at $1.3 billion, up 1.22% from the prior year.
- Current Deferred Revenue for Q1 2026 stood at $1.2 billion, down from $1.3 billion in the prior quarter.
- Over the last five years, Current Deferred Revenue for ALGN reached as high as $1.4 billion in Q4 2023 and fell as low as $1.2 billion in Q1 2022.
- Historically, Current Deferred Revenue has averaged $1.3 billion across 5 years, with a median of $1.3 billion in 2025.
- Across the five-year window, Current Deferred Revenue soared 40.47% in 2022 and decreased 6.76% in 2024, its largest moves.
- Year by year, Current Deferred Revenue stood at $1.3 billion in 2022, then climbed by 6.26% to $1.4 billion in 2023, then dropped by 6.76% to $1.3 billion in 2024, then climbed by 1.22% to $1.3 billion in 2025, then declined by 8.32% to $1.2 billion in 2026.
- Per Business Quant data, the three most recent Current Deferred Revenue figures were $1.2 billion in Q1 2026, $1.3 billion in Q4 2025, and $1.4 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.24 Bn |
| Dec 31, 2025 | 1.35 Bn |
| Sep 30, 2025 | 1.38 Bn |
| Jun 30, 2025 | 1.32 Bn |
| Mar 31, 2025 | 1.32 Bn |
| Dec 31, 2024 | 1.33 Bn |
| Sep 30, 2024 | 1.38 Bn |
| Jun 30, 2024 | 1.38 Bn |
| Mar 31, 2024 | 1.41 Bn |
| Dec 31, 2023 | 1.43 Bn |
| Sep 30, 2023 | 1.41 Bn |
| Jun 30, 2023 | 1.40 Bn |
| Mar 31, 2023 | 1.38 Bn |
| Dec 31, 2022 | 1.34 Bn |
| Sep 30, 2022 | 1.29 Bn |
| Jun 30, 2022 | 1.24 Bn |
| Mar 31, 2022 | 1.21 Bn |
| Dec 31, 2021 | 1.15 Bn |
| Sep 30, 2021 | 1.07 Bn |
| Jun 30, 2021 | 975.93 Mn |